本文選題：會(huì)計(jì)造假 + 關(guān)聯(lián)方交易��； 參考：《遼寧大學(xué)》2014年碩士論文

【摘要】：隨著世界資本市場(chǎng)高速發(fā)展和經(jīng)濟(jì)一體化的大背景下，我國(guó)的證券市場(chǎng)自建立以來(lái)，上市公司的會(huì)計(jì)造假問(wèn)題就層出不窮。會(huì)計(jì)造假問(wèn)題已經(jīng)成為我們每年的老生常談的話題，它已經(jīng)嚴(yán)重阻礙我國(guó)經(jīng)濟(jì)的發(fā)展。它直接導(dǎo)致公司股票價(jià)格的大幅下跌，造成投資者的巨額損失，同時(shí)阻礙公司自身的發(fā)展，使公司面臨退市的風(fēng)險(xiǎn)，甚至還阻礙證券市場(chǎng)健康發(fā)展、影響資源有效配置、降低證券市場(chǎng)公信力等等，使人們震驚的同時(shí)也引發(fā)了人們對(duì)會(huì)計(jì)造假問(wèn)題的深刻反思。因此如何建立有效防范會(huì)計(jì)造假體系是亟待解決的問(wèn)題。 ZXYY上市公司在傳統(tǒng)醫(yī)藥行業(yè)中面臨激烈競(jìng)爭(zhēng)，不斷擴(kuò)大市場(chǎng)份額，不惜以造假手段來(lái)達(dá)到追求利潤(rùn)的目的，使公司陷入重重危機(jī)之中。本文通過(guò)闡述了ZXYY上市公司會(huì)計(jì)造假手段，分析該公司的會(huì)計(jì)造假動(dòng)機(jī)及會(huì)計(jì)造假的內(nèi)外部原因，說(shuō)明完善管理層薪酬制度、規(guī)范上市公司的法人治理結(jié)構(gòu)、加強(qiáng)內(nèi)外部監(jiān)督的必要性，，進(jìn)而提出對(duì)策和建議以保障廣大投資者尤其是中小投資者的利益。全文寫(xiě)作共分四個(gè)部分。 第一部分緒論。主要介紹了本文的研究背景和研究意義、研究?jī)?nèi)容與研究方法、相關(guān)文獻(xiàn)綜述，闡述了本文所采用的研究方法和遵循的研究思路以及本文的基本框架。 第二部分案例描述，主要介紹了ZXYY上市公司的基本情況，對(duì)該公司會(huì)計(jì)造假事件的回顧，及其會(huì)計(jì)造假問(wèn)題進(jìn)行具體描述，包括：虛增資產(chǎn)、利用關(guān)聯(lián)方交易虛增利潤(rùn)、偽造經(jīng)營(yíng)業(yè)績(jī)過(guò)度融資等。 第三部分案例分析。首先對(duì)分析中運(yùn)用到的會(huì)計(jì)造假的相關(guān)理論進(jìn)行闡述，然后運(yùn)用相關(guān)理論對(duì)ZXYY上市公司會(huì)計(jì)造假的原因進(jìn)行分析。 第四部分結(jié)論與建議。針對(duì)該公司存在的具體會(huì)計(jì)造假問(wèn)題提出治理建議。從公司的法人治理結(jié)構(gòu)、完善管理層薪酬制度、提高獨(dú)立董事職業(yè)道德、加強(qiáng)外部審計(jì)師獨(dú)立性、增強(qiáng)市場(chǎng)監(jiān)督力度等方面提出改進(jìn)建議。完善公司內(nèi)外部控制、監(jiān)督會(huì)計(jì)造假的關(guān)鍵環(huán)節(jié)，從而更好保護(hù)廣大投資者利益。
[Abstract]:With the rapid development of the world capital market and the background of economic integration, the accounting fraud of listed companies has emerged one after another since the establishment of China's securities market. Accounting fraud has become a common topic every year, which has seriously hindered the development of our economy. It directly leads to a sharp decline in the stock price of the company, resulting in huge losses for investors, and at the same time hindering the development of the company itself, making the company face the risk of delisting from the market, even hindering the healthy development of the securities market and affecting the effective allocation of resources. Reducing the credibility of the securities market and so on, people are shocked, but also triggered a profound reflection on accounting fraud. Therefore, how to establish an effective accounting fraud prevention system is an urgent problem to be solved. ZXYY listed companies face fierce competition in the traditional medicine industry, expand their market share, do not hesitate to use fake means to achieve the goal of pursuing profits, so that the company is in a crisis. This paper expounds the accounting fraud means of ZXYY listed companies, analyzes its accounting fraud motive and the internal and external reasons of accounting fraud, and explains how to perfect the management compensation system and standardize the corporate governance structure of listed companies. Strengthen the necessity of internal and external supervision, and then put forward countermeasures and suggestions to protect the interests of the majority of investors, especially small and medium-sized investors. Full-text writing is divided into four parts. The first part is introduction. This paper mainly introduces the research background and significance, the research content and research methods, the related literature review, and describes the research methods adopted in this paper, followed the research ideas and the basic framework of this paper. The second part of the case description, mainly introduces the basic situation of ZXYY listed companies, the review of the accounting fraud of the company, as well as the specific description of accounting fraud, including: false assets, using related party transactions to increase profits, Falsified operating performance excessive financing and so on. The third part is case analysis. First of all, the relevant theories of accounting fraud used in the analysis are expounded, and then the reasons of accounting fraud of ZXYY listed companies are analyzed. Part IV: conclusions and recommendations. In view of the company's specific accounting fraud problems put forward management recommendations. Some suggestions are put forward from the aspects of the corporate governance structure, the improvement of management compensation system, the improvement of the professional ethics of independent directors, the strengthening of the independence of external auditors, and the strengthening of market supervision. Perfect the internal and external control of the company, supervise the key link of accounting fraud, so as to better protect the interests of the majority of investors.
【學(xué)位授予單位】：遼寧大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類(lèi)號(hào)】：F832.51;F426.72;F406.7

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張萌;;從內(nèi)部控制環(huán)境看上市公司財(cái)務(wù)舞弊——以紫鑫藥業(yè)為例[J];財(cái)會(huì)通訊;2012年20期

2 陳歡;;淺析紫鑫藥業(yè)財(cái)務(wù)造假案[J];當(dāng)代經(jīng)濟(jì);2013年12期

3 馮群英;;上市公司財(cái)務(wù)報(bào)告舞弊及審計(jì)對(duì)策[J];財(cái)會(huì)研究;2010年20期

4 林波;;紫鑫藥業(yè)財(cái)務(wù)騙局與監(jiān)管迷失解析[J];內(nèi)蒙古財(cái)經(jīng)學(xué)院學(xué)報(bào);2011年04期

5 郝玉貴;劉李曉;;關(guān)聯(lián)方交易舞弊風(fēng)險(xiǎn)內(nèi)部控制與審計(jì)——基于紫鑫藥業(yè)案例的研究[J];審計(jì)與經(jīng)濟(jì)研究;2012年04期

6 黃荔潔;;淺談上市公司會(huì)計(jì)造假問(wèn)題[J];商業(yè)文化(上半月);2011年10期

7 張雪峰;;從紫鑫藥業(yè)審計(jì)失敗案看“未披露關(guān)聯(lián)方交易”審計(jì)[J];商業(yè)會(huì)計(jì);2012年17期

8 楊德明;劉靜;趙璨;;媒體監(jiān)督與財(cái)務(wù)丑聞——針對(duì)紫鑫藥業(yè)的案例研究[J];中大管理研究;2012年04期

9 田武宗;會(huì)計(jì)造假的動(dòng)機(jī)與行為分析[J];孝感學(xué)院學(xué)報(bào);2003年02期

10 張春英;;淺談上市公司財(cái)務(wù)造假手段及防范措施[J];行政事業(yè)資產(chǎn)與財(cái)務(wù);2011年14期

相關(guān)博士學(xué)位論文 前1條

1 李秋蕾;中國(guó)上市公司會(huì)計(jì)舞弊監(jiān)管制度研究[D];天津財(cái)經(jīng)大學(xué);2012年

本文編號(hào)：1793141